227 related articles for article (PubMed ID: 29483205)
1. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study.
Esposito D; Ragnarsson O; Granfeldt D; Marlow T; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 May; 178(5):459-469. PubMed ID: 29483205
[TBL] [Abstract][Full Text] [Related]
2. The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes.
Portocarrero-Ortiz LA; Vergara-Lopez A; Vidrio-Velazquez M; Uribe-Diaz AM; García-Dominguez A; Reza-Albarrán AA; Cuevas-Ramos D; Melgar V; Talavera J; Rivera-Hernandez AJ; Valencia-Méndez CV; Mercado M;
J Clin Endocrinol Metab; 2016 Nov; 101(11):3997-4004. PubMed ID: 27428551
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register.
Arnardóttir S; Järås J; Burman P; Berinder K; Dahlqvist P; Erfurth EM; Höybye C; Larsson K; Ragnarsson O; Ekman B; Edén Engström B
Eur J Endocrinol; 2022 Feb; 186(3):329-339. PubMed ID: 35007208
[TBL] [Abstract][Full Text] [Related]
4. Time trends of mortality in patients with non-functioning pituitary adenoma: a Swedish nationwide study.
Olsson DS; Bryngelsson IL; Ragnarsson O
Pituitary; 2017 Apr; 20(2):218-224. PubMed ID: 27743172
[TBL] [Abstract][Full Text] [Related]
5. The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study.
Varadhan L; Reulen RC; Brown M; Clayton RN
Pituitary; 2016 Jun; 19(3):251-61. PubMed ID: 26724807
[TBL] [Abstract][Full Text] [Related]
6. Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study.
Olsson DS; Nilsson AG; Bryngelsson IL; Trimpou P; Johannsson G; Andersson E
J Clin Endocrinol Metab; 2015 Jul; 100(7):2651-8. PubMed ID: 25946030
[TBL] [Abstract][Full Text] [Related]
7. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
8. Patients lost to follow-up in acromegaly: results of the ACROSPECT study.
Delemer B; Chanson P; Foubert L; Borson-Chazot F; Chabre O; Tabarin A; Weryha G; Cortet-Rudelli C; Raingeard I; Reznik Y; Reines C; Bisot-Locard S; Castinetti F
Eur J Endocrinol; 2014 May; 170(5):791-7. PubMed ID: 24591552
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of acromegaly: the patient's perspective.
Kreitschmann-Andermahr I; Siegel S; Kleist B; Kohlmann J; Starz D; Buslei R; Koltowska-Häggström M; Strasburger CJ; Buchfelder M
Pituitary; 2016 Jun; 19(3):268-76. PubMed ID: 26742496
[TBL] [Abstract][Full Text] [Related]
10. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, incidence, comorbidities, and treatment patterns among Japanese patients with acromegaly: a descriptive study using a nationwide claims database.
Matsubayashi K; Kawakami K
Endocr J; 2020 Oct; 67(10):997-1006. PubMed ID: 32522909
[TBL] [Abstract][Full Text] [Related]
12. Treatment of persistent and recurrent acromegaly.
Del Porto LA; Liubinas SV; Kaye AH
J Clin Neurosci; 2011 Feb; 18(2):181-90. PubMed ID: 21167718
[TBL] [Abstract][Full Text] [Related]
13. Cost of management of invasive growth hormone-secreting macroadenoma.
Luque-Ramírez M; Paramo C; Varela da Costa C; García-Mayor RV
J Endocrinol Invest; 2007; 30(7):541-5. PubMed ID: 17848835
[TBL] [Abstract][Full Text] [Related]
14. [Not Available].
Mosbah H; Brue T; Chanson P
Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S10-S18. PubMed ID: 31606057
[TBL] [Abstract][Full Text] [Related]
15. Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.
Claessen KM; Kroon HM; Pereira AM; Appelman-Dijkstra NM; Verstegen MJ; Kloppenburg M; Hamdy NA; Biermasz NR
J Clin Endocrinol Metab; 2013 Dec; 98(12):4808-15. PubMed ID: 24081732
[TBL] [Abstract][Full Text] [Related]
16. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of medical treatment in patients with acromegaly in clinical practice.
Lee SY; Kim JH; Lee JH; Kim YH; Cha HJ; Kim SW; Paek SH; Shin CS
Endocr J; 2018 Jan; 65(1):33-41. PubMed ID: 28931779
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic trends and outcome of acromegaly: a single center experience over a 40-year period.
Karapanou O; Tzanela M; Christoforaki M; Papastathopoulou L; Moutsatsou P; Botoula E; Tsagarakis S
Hormones (Athens); 2016 Jul; 15(3):368-376. PubMed ID: 27394702
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas.
Xu D; Wu B; Li X; Cheng Y; Chen D; Fang Y; Du Q; Chen Z; Wang X
BMC Endocr Disord; 2019 Sep; 19(1):94. PubMed ID: 31477080
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the treatment of acromegaly].
Krysiak R; Okopień B; Marek B
Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
